Kevin R Kozak
Overview
Explore the profile of Kevin R Kozak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
2302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomoda K, Chiang H, Kozak K, Kwon G
Int J Radiat Biol
. 2016 Nov;
93(4):402-406.
PMID: 27827005
Purpose: The aim of tumor-specific chemoradiotherapy is to achieve synergistic anticancer effects with clinically acceptable toxicity. Our previous studies showed that Pluronic P85 augments radiation cancer cell killing of (±)-gossypol...
2.
Tomoda K, Tam Y, Cho H, Buehler D, Kozak K, Kwon G
Macromol Biosci
. 2016 Jul;
17(1).
PMID: 27365266
Triolimus is a multi-drug loaded polymeric micelle containing paclitaxel (PTX), 17-allylamino-17-demethoxygeldanamycin (17-AAG), and rapamycin (RAP). This study examines the radiosensitizing effect of Triolimus in vitro and in vivo. Radiosensitizing effects...
3.
Kruser T, Mehta M, Kozak K
J Clin Oncol
. 2016 Feb;
34(11):1281-2.
PMID: 26884565
No abstract available.
4.
Morris Z, Cannon D, Morris B, Bentzen S, Kozak K
J Thorac Oncol
. 2015 Aug;
10(11):1608-15.
PMID: 26317917
Introduction: Contralateral lung tumors in non-small-cell lung cancer (NSCLC) are classified as stage M1a yet may represent hematogenous metastases or synchronous primary tumors. The impact of these tumors on overall...
5.
Attia S, Okuno S, Robinson S, Webber N, Indelicato D, Bagaria S, et al.
Rare Tumors
. 2015 Aug;
7(2):5992.
PMID: 26266019
We report a response to pazopanib in a 69-year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor. To our knowledge, this case...
6.
Tomoda K, Chiang C, Kozak K, Kwon G
AAPS J
. 2015 Aug;
17(6):1369-75.
PMID: 26246329
Chemoradiotherapy, the combination of chemotherapy and radiotherapy to treat cancer, has the potential to enhance local therapeutic effects and simultaneously treat systemic disease. However, chemoradiotherapy may also enhance normal tissue...
7.
Mullvain J, Kozak K, Moody J, Campbell T
Support Care Cancer
. 2015 Feb;
23(9):2643-8.
PMID: 25663509
Purpose: Preventive care, referring to medical interventions with anticipated long-term benefits, is often inappropriately continued near the end of life. We examined the use of statin medications in patients with...
8.
Kuo A, Ancukiewicz M, Kozak K, Yock T, Padera T
Radiat Oncol
. 2015 Jan;
10:5.
PMID: 25573181
Background: Thoracic and cardiac irradiation increases the risk of pulmonary and cardiovascular disease. In addition, radiation, often in combination with chemotherapy, can cause treatment-related pneumonitis. Previously, we showed that the...
9.
Cannon D, Mohindra P, Gondi V, Kruser T, Kozak K
J Neurooncol
. 2014 Oct;
121(1):151-7.
PMID: 25270349
Choroid plexus tumors (CPTs) are rare neoplasms of the central nervous system whose optimal management is not well defined. The Surveillance Epidemiology and End Results (SEER) Database from 1978 to...
10.
Borkenhagen J, Morris Z, Hoberg J, Kozak K, Shapiro L
Pract Radiat Oncol
. 2014 Sep;
4(5):294-297.
PMID: 25194097
No abstract available.